U.S. Food and Drug Administration officials have approved Omontys ( peginesatide ), a drug administered through monthly injections to treat anemia in patients with chronic kidney disease.

It is not always clear why people of a certain ethnicity are more at risk of disease than others. Regardless, knowing who is at risk of lupus, for example, can help doctors make treatment decisions.

Kidney transplants save lives, but only if recipients' bodies accept the new organ. Now, scientists are working on ways to prevent kidney transplant rejection.

A kidney transplant can save a person's life. But people with a transplanted kidney often have to take anti-rejection drugs for much of their lives. A new discovery may make these drugs unnecessary for some.

As you get older, your body becomes less resilient in the face of diseases like diabetes and kidney disease. But a weakening body does not mean you are doomed. There are steps you can take to protect your health.

A kidney transplant can save the life of a person with kidney failure. But treatment for kidney failure does not end after the patient gets a new organ. Doctors must continue working to make sure the new kidney works.

Today, people with HIV/AIDS can expect to live longer, healthier lives with the help of medications. Some of these medications, however, may come with dangerous side effects.

Certain populations, such as African Americans, are less likely than whites to get a kidney transplant when they need it. This may be happening because patients do not know about the entire transplant process.

Good news for pregnant moms carrying a baby with a rare birth defect affecting the urethra: treatment using a small tube called a shunt can reduce serious health risks for your baby.

Across the United States, hundreds of thousands of dialysis patients are waiting for new kidneys. Unfortunately, there are not enough organs to go around. Paperless donor screening may partially fix this problem.